Key result
The matrix 1 gene of the Influenza virus was cloned within prokaryotic DH5 alpha E. coli to generate recombinant M1 protein for potential vaccine and diagnostic development.
Why the study?
Developing a comprehensive vaccine conferring cross-strain protection against influenza requires targeting conserved genomic regions like the M1 protein, because current hemagglutinin and neuraminidase antigens suffer high mutation rates.
Cloning the conserved M1 gene of the influenza virus in E. coli provides a foundation for developing cross-strain vaccines and diagnostic tests.
Offers a platform for conserved influenza antigen research; leaves open efficacy in human vaccine or diagnostic applications.
Influenza virus is a highly infectious member of the family orthomyxoviridae known worldwide due to its capability to cause pandemic influenza.Due to its high morbidity index and rate of spread a comprehensive vaccine that induce protection against different strains has been a research emphasis.For the development of an effective vaccine candidate the conserved areas within the genome should be targeted for the hemagglutinin and neuraminidase antigens currently employed for the same suffers a high mutation rate.M1 protein appears to be a highly attractive antigen able to confer cross strain protection amongst various strains of Influenza.It has been earlier shown that the expression of the matrix M1 gene alone can result in the induction of VLP budding within cells.M1 protein thus can be efficiently utilised in even extension of immunity to multiple viral genera or even families provided using the molecular biology field co-expression of those proteins along with the M1 protein are successful in cells.This work is focused on the cloning of the matrix 1 gene within the prokaryotic DH5 alpha E.coli and generation of the Recombinant M1 protein which when purified, can be used for vaccine trials and the development of diagnostic tests
No takes yet. Share an insight, caveat, or question.
Shobith Suresh (2023) studied Influenza virus. Cloning of the matrix 1 (M1) gene was evaluated on Generation of Recombinant M1 protein. The matrix 1 gene of the Influenza virus was cloned within prokaryotic DH5 alpha E. coli to generate recombinant M1 protein for potential vaccine and diagnostic development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: